8-K filing — Merlin, Inc. (MRLN)
Filed: 2026-10-27 AccNo: 0001628280-26-067435 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-27 AccNo: 0001628280-26-067435 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Merlin, Inc. has scheduled a presentation and Q&A session to review its financial performance for the third quarter ended September 30, 2026.
TD Cowen analyst Gautam Khanna maintains Merlin (NASDAQ:MRLN) with a Buy and lowers the price target from $8 to $4.